Jeffrey S. Heier
Chief Scientific Officer · OCULAR THERAPEUTIX, INC
- 2024
- Oct 6, 2026
- 9
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey S. Heier files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Pravin Dugel - $1.94M in OCUL purchases and sales in the last 12 months
- Richard L. Md Lindstrom - $461K in OCUL purchases and sales in the last 12 months
- Namrata Saroj - $278K in OCUL purchases and sales in the last 12 months
- Nadia Waheed - $221K in OCUL purchases and sales in the last 12 months
- Donald Notman - $216K in OCUL purchases and sales in the last 12 months
- Peter Kaiser - $187K in OCUL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey S. Heier?
Jeffrey S. Heier is a corporate insider, tracked as Chief Scientific Officer of OCULAR THERAPEUTIX, INC (OCUL). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeffrey S. Heier submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Jeffrey S. Heier been buying or selling stock?
Recorded transactions: 0 open-market purchases and 8 open-market sales ($383K) across all tracked filings.
